BMJ: Chest-thumpadded needs to be cautious! Breast implants confirmed to be linked to rare cancers

According to the FDA, 573 people worldwide have been infected with the disease as a result of breast implants and have caused 33 deathsOf these, 481 cases were attributable significantly to Allergan's Biocell breast augmentation, and 12 deaths were associated with thisDrJeffrey Shuren, director of the FDA's Center for Equipment and Radiological Health, said: "It is this wealth of death data that has led us to make the recall decision"
transmutation large cell lymphomathe risk of breast augmentation surgery has been the focus of plastic surgery, as early as 1997 has been reported for the first time between breast implants and diseaseThe FDA has been looking at the link between breast implants and cancer since 2011, and in this recall they have announced that breast implants are linked to interdegenerative large cell lymphoma (BIA-ALCL)Picture Source: References
Cederna, former president of the American Plastic Surgery Foundation, said: "Interdegenerative large cell lymphoma (BIA-ALCL) is not breast cancer, but a rare, treatable T-cell lymphomaIt usually occurs after surgery such as breast augmentation surgery, prosthetic implants after breast cancer, and is characterized by fluid swelling around the breast implantsAlthough the cancer is treatable, it can also multiply and metastasis to threaten the patient's life if not detected in time"
textured surface is the culprit
in general, breast implant prostheses are divided into textureless glossy and textured surfaces, the reason for designing textured surfaces, because it can prevent the prosthesis to slide at willBut it is also precisely because of the non-smoothness of the texture, often with the tissue around the implant site friction to cause inflammation, and thus the development of tissue fluid and swelling, if not treated in a timely manner, may lead to the occurrence of BIA-ALCL, a rare cancerDrMark Clemens, a plastic surgeon at the Anderson Cancer Center in Houston,, has been studying lymphoma and suspects that the culprits in BIA-ALCL may be related to the textured surface of the implanted prostheticAfter years of investigation, the FDA acknowledged this correlationbreast implants and BIA-ALCL formation process Image source: FDA, there are many breast implant syllabea products on the market, but this time the FDA only asked Allergan to recall breast prosthetics on its textured surface, because, according to FDA data analysis, the use of breast prosthetics with the same textured surface causes a 6 times higher risk of developing BIA-ALCLAllergan recalls products Photo source: References,the probability of cancer is small
across the U.Sbreast prosthetic market, the vast majority of breast prosthetic products are textured glossy, while textured surface breast prosthetics account for only 10% of the marketWhat's more, Allergan's textured surface breast prosthetics account for less than 5% of the marketAmy Abernethy, theFDA's chief deputy director, also said the overall incidence of the disease appears to be relatively low, and that if consumers who implant the breast implant do not experience any discomfort, it is not recommended to remove the implantIf symptoms of discomfort occur, it is best to communicate with the relevant physician, understand the situation before making treatmentconclusionAs Diana Zuckerman, director of the National Center for Health Research on Breast Implants in the United States, puts it: "When a woman decides to have a breast implant for reconstruction after a mastectomy or breast augmentation, she should not put her life at risk of lymphoma." "
so, Amy is at risk and has to be cautious about breast augmentation.